Kuhn Cuellar, Luis
Friedrich, Andreas
Gabernet, Gisela
de la Garza, Luis
Fillinger, Sven
Seyboldt, Adrian
Koch, Tobias
zur Oven-Krockhaus, Sven
Wanke, Friederike
Richter, Sandra
Thaiss, Wolfgang M.
Horger, Marius
Malek, Nisar
Harter, Klaus
Bitzer, Michael
Nahnsen, Sven https://orcid.org/0000-0002-4375-0691
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB/TR 209, SFB 1101, SFB/TR 261, KO-2313/6-1, KO-2313/2)
Exzellenzcluster Mikrobiologie (EXC-2124)
Bundesministerium für Bildung und Forschung (01ZX1301F, 01ZX1301A, 01ZX1601G)
Eberhard Karls Universität Tübingen
Article History
Received: 26 June 2020
Accepted: 21 January 2022
First Online: 7 February 2022
Declarations
:
: For the illustrated use case on liver cancer, we received ethical approval by the ethical commission of the University Hospital of Tübingen.
: Not applicable.
: The authors declare that they have no competing interests.